Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks88 Energy Regulatory News (88E)

Share Price Information for 88 Energy (88E)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.1575
Bid: 0.155
Ask: 0.16
Change: 0.00 (0.00%)
Spread: 0.005 (3.226%)
Open: 0.1575
High: 0.1575
Low: 0.156
Prev. Close: 0.1575
88E Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of Rights Issue Shortfall Placement

30 Aug 2023 12:07

RNS Number : 8342K
88 Energy Limited
30 August 2023
 

 

88 Energy Limited

 

Completion of Rights Issue Shortfall Placement

 

88 Energy Limited (ASX:88E, AIM:88E, OTC:EEENF) (88 Energy or the Company) is pleased to announce the completion of its Shortfall Offer Placement from the non-renounceable rights issue (Rights Issue), at an issue price of A$0.006/£0.0031 per Share.

The Rights Issue closed at 5:00pm AWST on 22 August 2023 with results from the processing of valid applications announced on 29 August 2023, with the Company issuing 553,070,348 New Shares to eligible shareholders under the Rights Issue.

As a result of the strong inbound demand received from other investors during the Rights Issue and subsequent Shortfall Offer process, the Company has received firm commitments to place in full all of the New Shares not taken up under the Rights Issue via the Shortfall Offer representing 1,457,716,470 New Shares to be issued (Shortfall Offer Placement), of which 675,000,000 ordinary shares will be issued under the Company's placement capacity pursuant to ASX Listing Rules 7.1 and 782,716,470 ordinary shares under Listing Rules 7.1A. Shares issued under the Shortfall Offer Placement include the Capital Development Shares referred to below.

The proceeds of the Rights Issue and Shortfall Offer Placement of A$8.0 million / approx. £4.1 million (before costs), which together with the Company's existing cash reserves (A$7.3 million (approx. £3.8 million) as at 30 June 2023), will strengthen the Company's balance sheet and provide the Company with further capital to fund 88 Energy's share of the Hickory-1 well flow test at Project Phoenix, permitting and planning for a potential new well at Project Leonis. The issue of A$4 million worth of Capital Development Shares is expected to save the Company at least an equivalent amount in cash costs on development wells for Project Longhorn production growth, so that the value of the benefit to the Company from the Rights Issue and Shortfall Placement totals A$12.0 million / approx. £6.4 million (before costs).

The Company has agreed to part fund its share of the first two new wells at the recently acquired Bighorn Phase 2 acreage anticipated to cost US$3.0 million (net) in development capital, through the issuance of A$4.0 million worth of 88 Energy shares as part of the Shortfall Offer Placement (approximately 667 million shares at a deemed issue price equal to the offer price of A$0.006 per share under the Rights Issue and the Shortfall Offer Placement) to Lonestar I, LLC (Lonestar) (Capital Development Shares).

The Capital Development Shares will be held in escrow and subject to certain restrictions and will only be released from escrow following approval by 88 Energy. Lonestar has the option to dispose of Capital Development Shares, subject to certain restrictions under the agreement. Any proceeds from the disposal of the Capital Development Shares received by Lonestar are to be held on trust for 88 Energy until the associated invoices are received and approved by 88 Energy for the capital development program. A reconciliation process and payment of any outstanding amounts due (in cash) will occur prior to year-end 2023.

Total New Shares to be issued under the Shortfall Offer Placement represent approximately 7% of all Shares of the Company publicly on offer. The New Shares issued under the Rights Issue on 29 August 2023 commenced trading on AIM on 30 August 2023. Settlement of the Shortfall Offer Placement on ASX is scheduled for 7 September 2023, with normal trading on ASX commencing on 8 September 2023. Application will be made for admission of the Shortfall Offer Placement Shares to trading on AIM ("Admission"), with Admission and settlement expected to occur on 8 September 2023. All of the New Shares will rank equally with existing 88 Energy shares on issue.

Euroz Hartleys Limited acted as lead Manager and bookrunner to the Shortfall Offer Placement. Cenkos Securities Plc acted as nominated adviser and broker to the Shortfall Offer Placement in the United Kingdom. Inyati Capital Pty Ltd acted as co-manager to the Shortfall Offer Placement. Commission for the Shortfall Offer Placement was 6% (plus GST) of total funds raised across Euroz Hartleys Limited, Inyati Capital Pty Ltd and Cenkos Securities Plc. This fee does not apply to the Capital Development Shares.

Following the issue of the New Shares under the Rights offering and Shortfall Placement, the Company will have 22,118,655,043 ordinary shares on issue, all of which have voting rights. The figure of 22,118,655,043 ordinary shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or change their interest in, the Company.

 

This announcement has been authorised by the Board.

 

Media and Investor Relations:

 

88 Energy Ltd

Ashley Gilbert, Managing Director

 

Tel: +61 8 9485 0990

Email:investor-relations@88energy.com

 

 

 

Fivemark Partners, Investor and Media Relations Tel: +61 410 276 744

Michael Vaughan Tel: +61 422 602 720

 

EurozHartleys Ltd

Dale Bryan Tel: + 61 8 9268 2829

 

Cenkos Securities Tel: + 44 131 220 6939

Neil McDonald / Derrick Lee

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEFLFILTSIIVIV
Date   Source Headline
4th Mar 20194:40 pmRNSSecond Price Monitoring Extn
4th Mar 20194:35 pmRNSPrice Monitoring Extension
4th Mar 20197:00 amRNSAdditional Interim Results from Drilling
1st Mar 20199:05 amRNSSecond Price Monitoring Extn
1st Mar 20199:00 amRNSPrice Monitoring Extension
1st Mar 20197:45 amRNSInterim Results from Drilling
26th Feb 20197:30 amRNSDrilling of Primary Target Interval Commences
25th Feb 201910:07 amRNSASX Lodgement of Annual Report
22nd Feb 20197:00 amRNSOperations Update: Surface Casing Successfully Run
18th Feb 20197:00 amRNSOperations Update
15th Feb 20197:00 amRNSOperations Update - Spud on Schedule
5th Feb 20197:00 amRNSOperations Update - Rig Mobilisation Under Way
31st Jan 20197:00 amRNSCorporate Presentation
25th Jan 20197:00 amRNSQuarterly Report & Appendix 5B
24th Jan 20197:00 amRNSOperations Update - Ice Road Nears Completion
17th Jan 20198:00 amRNSOperations Update - Permit to Drill Approved
7th Jan 20197:00 amRNSOperations Update
20th Dec 20187:00 amRNSOperations Update
17th Dec 20187:00 amRNSOperations Update
9th Nov 201811:20 amRNSResult of Placing
8th Nov 20187:00 amRNSProposed placing to raise up to £5.9 million
7th Nov 20187:00 amRNSOperations Update
31st Oct 20187:00 amRNSIssued Share Capital & Appendix 3B
30th Oct 20187:00 amRNSPassing of Brent Villemarette, Non Exec Director
29th Oct 20187:19 amRNSRights Issue Results and Shortfall Notice
29th Oct 20187:00 amRNSQuarterly Report & Appendix 5B
24th Oct 20181:43 pmRNSReplacement: Options Exercise & Performance Rights
24th Oct 20189:46 amRNSExercise of Options & Issue of Performance Rights
23rd Oct 20187:00 amRNSConventional Portfolio Update
12th Oct 20187:46 amRNSRights Issue - Dispatch of Offer Document
5th Oct 201811:23 amRNSRights Issue Timetable - Clarification
5th Oct 20187:00 amRNSRights Issue Notice
3rd Oct 20187:00 amRNSNon-Renounceable Rights Issue / Open Offer
28th Sep 20187:00 amRNSAddendum to Notice of Meeting
28th Sep 20187:00 amRNSOperations Update
17th Sep 20182:16 pmRNSNotice of General Meeting
11th Sep 20187:00 amRNSCorporate Presentation
5th Sep 20188:53 amRNSInterim Report
3rd Sep 201810:18 amRNSExercise of Options
29th Aug 20187:12 amRNSOperations Update
3rd Aug 20187:00 amRNSCorporate Presentation
30th Jul 20187:00 amRNSOperations Update
18th Jul 20187:00 amRNSQuarterly Report
3rd Jul 201811:05 amRNSSecond Price Monitoring Extn
3rd Jul 201811:00 amRNSPrice Monitoring Extension
2nd Jul 20187:04 amRNSOperations Update
27th Jun 201811:05 amRNSSecond Price Monitoring Extn
27th Jun 201811:00 amRNSPrice Monitoring Extension
27th Jun 20189:05 amRNSSecond Price Monitoring Extn
27th Jun 20189:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.